<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T06:39:06Z</responseDate>
  <request identifier="oai:figshare.com:article/33937264" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33937264</identifier>
        <datestamp>2026-09-18T17:22:32Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Overview of inclusion and exclusion criteria T-ScEmo4ALL Plus&lt;sup&gt;+&lt;/sup&gt;.&lt;/p&gt;</dc:title>
          <dc:creator>Bente Raafs (25073068)</dc:creator>
          <dc:creator>Marjon Westerhof-Evers (25073071)</dc:creator>
          <dc:creator>Caroline van Heugten (3481124)</dc:creator>
          <dc:creator>Joke Spikman (21695459)</dc:creator>
          <dc:creator>Sophie Rijnen (23642223)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>traumatic brain injury</dc:subject>
          <dc:subject>specific target group</dc:subject>
          <dc:subject>shown promising effects</dc:subject>
          <dc:subject>primary outcome measures</dc:subject>
          <dc:subject>least 8 participants</dc:subject>
          <dc:subject>case experimental design</dc:subject>
          <dc:subject>acquired brain injury</dc:subject>
          <dc:subject>reduced social participation</dc:subject>
          <dc:subject>social cognition disorders</dc:subject>
          <dc:subject>impaired social cognition</dc:subject>
          <dc:subject>comorbid neuropsychiatric problems</dc:subject>
          <dc:subject>effective treatment strategies</dc:subject>
          <dc:subject>comorbid neuropsychiatric symptoms</dc:subject>
          <dc:subject>three baseline lengths</dc:subject>
          <dc:subject>complicate social functioning</dc:subject>
          <dc:subject>treatment social cognition</dc:subject>
          <dc:subject>treatment ), t1</dc:subject>
          <dc:subject>scemo may offer</dc:subject>
          <dc:subject>social cognition</dc:subject>
          <dc:subject>neuropsychiatric problems</dc:subject>
          <dc:subject>neuropsychiatric symptoms</dc:subject>
          <dc:subject>social functioning</dc:subject>
          <dc:subject>treatment ),</dc:subject>
          <dc:subject>tbi ),</dc:subject>
          <dc:subject>year follow</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>valuable addition</dc:subject>
          <dc:subject>secondary outcomes</dc:subject>
          <dc:subject>randomly assigned</dc:subject>
          <dc:subject>partner relationships</dc:subject>
          <dc:subject>particular importance</dc:subject>
          <dc:subject>neurorehabilitation practices</dc:subject>
          <dc:subject>may result</dc:subject>
          <dc:subject>maintenance phases</dc:subject>
          <dc:subject>main aim</dc:subject>
          <dc:subject>growing number</dc:subject>
          <dc:subject>emotional dysregulation</dc:subject>
          <dc:subject>emotion regulation</dc:subject>
          <dc:subject>cases contribute</dc:subject>
          <dc:subject>baseline single</dc:subject>
          <dc:description>&lt;p&gt;Overview of inclusion and exclusion criteria T-ScEmo4ALL Plus&lt;sup&gt;+&lt;/sup&gt;.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:22:27Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358008.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Overview_of_inclusion_and_exclusion_criteria_T-ScEmo4ALL_Plus_sup_sup_p_/33937264</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
